04/30/2024
4:26 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:46 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 10-K/A | |
04/19/2024
4:10 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
9:08 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
04/18/2024
7:21 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
04/15/2024
4:22 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
4:13 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
|
04/15/2024
5:00 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
04/02/2024
5:01 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
4:09 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:08 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
03/11/2024
4:16 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
02/28/2024
4:09 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
9:40 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
02/26/2024
4:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
02/14/2024
5:03 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:37 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
3:16 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
5:36 PM | NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Rehnquist Janet (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form PRE 14A | |
12/29/2023
3:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:30 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K/A | |
11/22/2023
3:31 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
11/22/2023
3:32 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form ARS | |
11/21/2023
4:23 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
3:05 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:04 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
8:19 AM | Gorovitz Aaron (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
8:15 AM | Hurvitz Chaim (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:48 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
08/31/2023
4:20 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
11:14 AM | Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
8:24 AM | Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:10 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2023
4:15 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
9:21 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
06/07/2023
4:18 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K/A | |
06/06/2023
3:27 PM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
7:00 AM | NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
